In placebo-controlled trials, cholelithiasis was reported in 1.5% and 0.4% of patients treated with Ozempic injection 0.5 mg and 1 mg, respectively, and not reported in placebo-treated patients
Semaglutide is a medication known as a GLP-1 receptor agonist
1990: Mojsov moved back to New York and entrusted her colleague Habener with their patent filings
That simple recordkeeping feels small until missing it costs you weeks of progress, and thats where things get complicated
There is no good evidence for this, and it is worth being cautious about that framing
"I definitely had struggles because, I mean, I believed it too," she says